StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
26
This year
1
Publishing Date
2024 - 01 - 17
1
2023 - 11 - 27
1
2023 - 10 - 19
1
2023 - 09 - 06
1
2023 - 07 - 03
1
2023 - 06 - 14
1
2023 - 04 - 19
1
2023 - 03 - 24
1
2023 - 01 - 20
1
2023 - 01 - 18
1
2022 - 12 - 07
1
2022 - 11 - 16
1
2022 - 09 - 27
1
2022 - 08 - 10
1
2022 - 06 - 06
1
2022 - 02 - 15
1
2021 - 12 - 14
1
2021 - 10 - 27
1
2021 - 10 - 18
1
2021 - 10 - 05
1
2021 - 09 - 20
1
2021 - 09 - 15
1
2021 - 09 - 14
1
2021 - 06 - 04
1
2021 - 05 - 27
1
2021 - 05 - 19
1
Sector
Consumer durables
1
Electronic technology
4
Health services
1
Health technology
26
Manufacturing
2
Professional, scientific, and technical services
5
Technology services
1
Tags
Air
15
Alliances
20
America
82
Application
29
Biomarkers
23
Biotech
14
Biotech-beach
25
Blood
16
Cancer
51
Care
13
Cell
25
Collaboration
17
Companies
36
Conference
24
Contract
35
Covid
36
Covid-19
40
Diagnostic
122
Diagnostics
166
Disease
47
Drug
48
Earnings
18
Europe
15
Events
21
Expansion
13
Expected
32
Fda
16
Flow
16
Food
25
Genetic
27
Genetown
28
Genomic
20
Genomics
16
Global
281
Growing
68
Growth
368
Health
18
In vitro
18
Management
14
Market
886
Merge
14
Million
14
Molecular
35
N/a
1409
Rapid
15
Reach
50
Report
307
Research
257
Respiratory
14
Results
17
Services
35
Set
22
Solutions
19
System
29
Technology
60
Test
91
Therapy
26
Trial
28
Trials
21
Water
14
Entities
Abbott laboratories
22
Abbvie inc.
40
Abeona therapeutics inc.
21
Accuray incorporated
22
Actinium pharmaceuticals, inc.
16
Adaptimmune therapeutics plc
15
Amgen inc.
42
Anixa biosciences, inc.
16
Astellas pharma inc
23
Astrazeneca plc
32
Ati physical therapy inc - class a
38
Avrobio, inc.
23
Baxter international inc.
17
Biocardia, inc.
27
Biogen inc.
30
Biomarin pharmaceutical inc.
29
Biorestorative therapies, inc.
16
Bluebird bio, inc.
32
Brainsway ltd.
15
Bridgebio pharma, inc.
17
Bristol-myers squibb company
65
Celularity inc - class a
16
Charles river laboratories international, inc.
19
Crispr therapeutics ag
15
Eli lilly and company
88
Fate therapeutics, inc.
15
Fortress biotech, inc.
20
Genprex, inc.
29
Gilead sciences, inc.
52
Glaxosmithkline plc
24
Incyte corporation
37
Intellia therapeutics, inc.
17
Intra-cellular therapies inc.
33
Iovance biotherapeutics, inc.
15
Jaguar health, inc.
15
Johnson & johnson
103
Medtronic plc
30
Merck & company, inc.
31
Mustang bio, inc.
16
Neuronetics, inc.
35
Novartis ag
89
Ocugen, inc.
16
Orange
36
Orchard therapeutics plc
24
Pfizer, inc.
29
Poseida therapeutics, inc.
31
Precision biosciences, inc.
19
Regeneron pharmaceuticals, inc.
18
Regenxbio inc.
25
Rocket pharmaceuticals, inc.
16
Sanofi
113
Sarepta therapeutics, inc.
24
Sio gene therapies inc
25
Takeda pharmaceutical company limited
43
Taysha gene therapies, inc.
52
Thermo fisher scientific inc
26
Ultragenyx pharmaceutical inc.
18
Uniqure n.v.
36
Viewray, inc.
34
Voyager therapeutics, inc.
16
Symbols
ABBV
1
ABT
2
AMGN
3
ANPCF
1
ANPCY
1
AZN
1
AZNCF
1
BAX
1
BDX
4
BIIB
2
BIO
3
BIOC
1
BLUE
1
BSX
1
CSTL
1
CTLT
3
DHR
5
GE
2
GLAXF
1
GLW
1
GSK
1
IART
1
ICLR
1
IPGP
1
JNJ
1
KPTI
1
LLY
1
LZAGF
5
LZAGY
5
MDT
1
MLAB
1
NH
1
NINOF
1
NINOY
1
NVO
1
NVS
2
NVSEF
2
NVTA
1
RGNX
1
SNNUF
2
SNY
1
SNYNF
1
TAK
2
TECH
2
TEVJF
1
TMO
26
TXG
1
VTRS
1
Exchanges
Nasdaq
12
Nyse
26
Crawled Date
2024 - 01 - 17
1
2023 - 11 - 27
1
2023 - 10 - 19
1
2023 - 09 - 06
1
2023 - 07 - 03
1
2023 - 06 - 14
1
2023 - 04 - 19
1
2023 - 03 - 24
1
2023 - 01 - 20
1
2023 - 01 - 18
1
2022 - 12 - 07
1
2022 - 11 - 16
1
2022 - 09 - 27
1
2022 - 08 - 10
1
2022 - 06 - 06
1
2022 - 02 - 15
1
2021 - 12 - 14
1
2021 - 10 - 27
1
2021 - 10 - 18
1
2021 - 10 - 05
1
2021 - 09 - 20
1
2021 - 09 - 15
1
2021 - 09 - 14
1
2021 - 06 - 04
1
2021 - 05 - 27
1
2021 - 05 - 19
1
Crawled Time
02:00
1
11:00
1
12:00
1
13:20
1
13:30
1
14:00
3
14:15
1
15:00
2
15:15
1
15:30
1
16:00
3
18:00
2
20:00
1
22:00
4
23:00
3
Source
www.biospace.com
10
www.fda.gov
1
www.prnewswire.com
15
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapy
entities :
Thermo fisher scientific inc
save search
Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows
Published:
2024-01-17
(Crawled : 15:30)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
0.6%
|
O:
-1.11%
H:
0.0%
C:
0.0%
first
solution
software
cell
therapy
Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published:
2023-11-27
(Crawled : 23:00)
- prnewswire.com
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
11.65%
|
O:
-0.5%
H:
0.0%
C:
0.0%
KPTI
|
$1.265
-8.33%
-9.09%
1.3M
|
Health Technology
|
95.05%
|
O:
4.0%
H:
1.93%
C:
-7.72%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
1.01%
|
O:
0.03%
H:
0.85%
C:
0.44%
report
hope
treatment
research
global
virus
therapy
market
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Boehringer Ingelheim to Select Patients with NSCLC for Targeted Therapy Treatment
Published:
2023-10-19
(Crawled : 13:30)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
13.85%
|
O:
-2.02%
H:
0.0%
C:
0.0%
diagnostic
treatment
companion
agreement
therapy
Thermo Fisher Scientific Helps Accelerate Cell Therapy Manufacturing with a Next-Generation Platform of Gibco™ CTS™ Detachable Dynabeads™
Published:
2023-09-06
(Crawled : 22:00)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-1.99%
|
O:
-2.61%
H:
0.0%
C:
0.0%
cell
therapy
platform
Global Viral & Non-Viral Vector Manufacturing Market 2023 to 2027: Growing Prominence of Gene and Cell Therapy Products Fuels the Sector
Published:
2023-07-03
(Crawled : 22:00)
- prnewswire.com
LZAGY
|
$57.3
0.02%
33K
|
Professional, Scientific, and T...
|
Email alert
Add to watchlist
CTLT
|
$55.8
-0.29%
0.0%
1M
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
DHR
|
$236.36
-1.27%
0.0%
4.2M
|
Health Technology
|
Email alert
Add to watchlist
LZAGF
|
$579.0
-19.1%
49
|
Health Technology
|
Email alert
Add to watchlist
cell
global
growing
therapy
market
Global Cell & Gene Therapy Manufacturing Services Market Report 2023: Major Players Include Thermo Fisher Scientific, Merck, Charles River Laboratories International and Lonza
Published:
2023-06-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$579.0
-19.1%
49
|
Health Technology
|
-7.97%
|
O:
0.45%
H:
1.36%
C:
1.36%
NINOY
|
$9.86
-3.3%
4.6K
|
Manufacturing
|
-17.48%
|
O:
4.31%
H:
0.0%
C:
-1.7%
LZAGY
|
$57.3
0.02%
33K
|
Professional, Scientific, and T...
|
-8.28%
|
O:
2.0%
H:
0.0%
C:
-0.97%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
4.03%
|
O:
0.34%
H:
0.04%
C:
-1.46%
BLUE
|
$0.9583
-0.52%
-0.52%
6.5M
|
Health Technology
|
-73.31%
|
O:
1.62%
H:
7.03%
C:
2.39%
services
report
international
cell
global
therapy
market
Global Cell and Gene Therapy Biomanufacturing Markets Report 2022-2023 & 2031: Burgeoning Opportunities with a Robust Clinical Pipeline and Integration of Automation
Published:
2023-04-19
(Crawled : 15:00)
- prnewswire.com
LZAGF
|
$579.0
-19.1%
49
|
Health Technology
|
-10.83%
|
O:
1.28%
H:
0.01%
C:
-1.16%
LZAGY
|
$57.3
0.02%
33K
|
Professional, Scientific, and T...
|
-12.48%
|
O:
-1.78%
H:
0.74%
C:
0.67%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-6.43%
|
O:
-1.55%
H:
0.86%
C:
0.72%
GE
|
$152.94
-1.75%
0.0%
6M
|
Electronic Technology
|
58.09%
|
O:
0.11%
H:
0.74%
C:
0.46%
DHR
|
$236.36
-1.27%
0.0%
4.2M
|
Health Technology
|
-6.17%
|
O:
-0.64%
H:
0.44%
C:
0.1%
BIO
|
News
|
$281.02
-3.38%
-0.36%
370K
|
Health Technology
|
-38.9%
|
O:
-0.57%
H:
2.71%
C:
2.09%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-8.9%
|
O:
0.39%
H:
1.75%
C:
1.68%
TECH
|
$62.25
-0.77%
-0.77%
1.2M
|
Health Technology
|
-25.61%
|
O:
-0.33%
H:
1.39%
C:
1.11%
integration
report
pipeline
cell
global
therapy
Increasing Investments and Fundings in Cell and Gene Therapy Fuelling the Growth of Cell and Gene Therapy Biomanufacturing, Suggests BIS Research Study
Published:
2023-03-24
(Crawled : 16:00)
- prnewswire.com
LZAGF
|
$579.0
-19.1%
49
|
Health Technology
|
-2.39%
|
O:
-1.95%
H:
0.8%
C:
-0.28%
LZAGY
|
$57.3
0.02%
33K
|
Professional, Scientific, and T...
|
-1.27%
|
O:
-0.34%
H:
0.0%
C:
-0.03%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-1.43%
|
O:
-1.2%
H:
1.85%
C:
1.78%
GE
|
$152.94
-1.75%
0.0%
6M
|
Electronic Technology
|
69.96%
|
O:
-1.11%
H:
1.97%
C:
0.88%
DHR
|
$236.36
-1.27%
0.0%
4.2M
|
Health Technology
|
-2.67%
|
O:
-0.73%
H:
1.32%
C:
1.24%
BIO
|
News
|
$281.02
-3.38%
-0.36%
370K
|
Health Technology
|
-35.85%
|
O:
-0.78%
H:
1.8%
C:
1.77%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-2.27%
|
O:
0.19%
H:
1.66%
C:
1.55%
TECH
|
$62.25
-0.77%
-0.77%
1.2M
|
Health Technology
|
-12.78%
|
O:
-0.46%
H:
1.79%
C:
1.33%
investments
cell
research
therapy
growth
study
Market Forecasts for Immuno-Oncology Diagnostics 2023: Sector Represents a Revolution in Cancer Therapy
Published:
2023-01-20
(Crawled : 22:00)
- prnewswire.com
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
Email alert
Add to watchlist
ANPCY
|
$1.98
338.38%
930
|
Manufacturing
|
Email alert
Add to watchlist
BIO
|
News
|
$281.02
-3.38%
-0.36%
370K
|
Health Technology
|
Email alert
Add to watchlist
TXG
|
$28.96
-0.69%
-0.69%
3M
|
Health Technology
|
Email alert
Add to watchlist
NVTA
|
$0.019
0.0%
22M
|
Health Services
|
Email alert
Add to watchlist
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
Email alert
Add to watchlist
ANPCF
|
$0.148
641.22%
5K
|
Health Technology
|
Email alert
Add to watchlist
CSTL
|
$19.19
1.86%
1.82%
140K
|
Health Technology
|
Email alert
Add to watchlist
ICLR
|
$291.74
-0.1%
-0.1%
500K
|
Health Technology
|
Email alert
Add to watchlist
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
Email alert
Add to watchlist
NH
|
$1.35
-46.64%
-1.48%
0
|
Technology Services
|
Email alert
Add to watchlist
MLAB
|
$100.05
-1.08%
-1.09%
31K
|
Health Technology
|
Email alert
Add to watchlist
diagnostics
therapy
cancer
market
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published:
2023-01-18
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
13.48%
|
O:
1.12%
H:
0.0%
C:
-1.68%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-7.09%
|
O:
-2.5%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-5.79%
|
O:
-1.16%
H:
1.62%
C:
-0.54%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-6.25%
|
O:
-0.17%
H:
0.25%
C:
-2.96%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-6.91%
|
O:
0.56%
H:
0.97%
C:
-1.87%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-10.4%
|
O:
0.57%
H:
0.84%
C:
-0.01%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
0.76%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-16.01%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
11.36%
|
O:
-0.03%
H:
0.17%
C:
-1.01%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
109.86%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-4.82%
|
O:
-0.16%
H:
0.33%
C:
-1.5%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-7.47%
|
O:
-0.14%
H:
0.0%
C:
0.0%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-32.61%
|
O:
0.34%
H:
0.46%
C:
-2.45%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-3.5%
|
O:
1.36%
H:
0.33%
C:
-1.13%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-0.92%
|
O:
0.0%
H:
0.41%
C:
-1.87%
therapy
growth
FDA Grants De Novo Classification to HLA Typing Test for Use as a Companion Diagnostic with a T Cell Receptor Therapy for Metastatic or Unresectable Uveal Melanoma
Published:
2022-12-07
(Crawled : 14:00)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-1.56%
|
O:
-0.58%
H:
0.0%
C:
0.0%
fda
melanoma
test
diagnostic
grants
therapy
Thermo Fisher Scientific Introduces All-in-One AAV Production System for Scalable Gene Therapy Workflows and Commercial Applications
Published:
2022-11-16
(Crawled : 14:00)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
0.79%
|
O:
0.71%
H:
0.0%
C:
0.0%
system
commercial
therapy
Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers
Published:
2022-09-27
(Crawled : 23:00)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
6.4%
|
O:
0.65%
H:
0.0%
C:
0.0%
fda
thyroid
test
diagnostic
approval
therapy
Stem Cell Therapy Global Market Report 2022: Rising Research and Development Spending, and Increasing Healthcare Expenditure Present Future Opportunities
Published:
2022-08-10
(Crawled : 16:00)
- prnewswire.com
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-6.37%
|
O:
0.8%
H:
0.61%
C:
0.54%
research
global
report
therapy
market
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
Published:
2022-06-06
(Crawled : 13:20)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-2.63%
|
O:
-0.14%
H:
0.0%
C:
0.0%
research
solutions
vaccine
therapy
Thermo Fisher Scientific Introduces New Cell and Gene Therapy Integrated Commercial Packaging and Distribution Services
Published:
2022-02-15
(Crawled : 16:00)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-2.48%
|
O:
1.12%
H:
0.66%
C:
-1.9%
gene therapy
distribution
cel
services
therapy
commercialization
Worldwide Pharmaceutical Contract Development & Manufacturing Industry to 2026 - Growing Need for Cell and Gene Therapies Presents Opportunities
Published:
2021-12-14
(Crawled : 11:00)
- prnewswire.com
LZAGF
|
$579.0
-19.1%
49
|
Health Technology
|
-30.12%
|
O:
-2.62%
H:
0.0%
C:
0.0%
LZAGY
|
$57.3
0.02%
33K
|
Professional, Scientific, and T...
|
-28.77%
|
O:
-1.64%
H:
0.19%
C:
-0.71%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-14.69%
|
O:
-0.2%
H:
0.0%
C:
0.0%
DHR
|
$236.36
-1.27%
0.0%
4.2M
|
Health Technology
|
-24.54%
|
O:
-0.84%
H:
0.0%
C:
0.0%
CTLT
|
$55.8
-0.29%
0.0%
1M
|
Health Technology
|
-54.61%
|
O:
0.26%
H:
0.44%
C:
-0.68%
contract
cel
gene therapies
growing
gene therapy
therapy
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published:
2021-10-27
(Crawled : 20:00)
- fda.gov
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-10.62%
|
O:
0.44%
H:
2.01%
C:
0.82%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-4.85%
|
O:
2.03%
H:
3.33%
C:
0.07%
RGNX
|
$16.08
-5.58%
-5.91%
560K
|
Health Technology
|
-51.65%
|
O:
0.91%
H:
2.93%
C:
2.79%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-24.93%
|
O:
0.19%
H:
2.32%
C:
1.7%
disease
fda
gene therapies
therapy
gene therapy
rare
Outlook on the Regenerative Medicine Global Market to 2026 - Focus on Stem Cell Therapy, Biomaterial and Tissue Engineering Among Others
Published:
2021-10-18
(Crawled : 22:00)
- prnewswire.com
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-6.94%
|
O:
0.51%
H:
1.02%
C:
0.19%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
13.04%
|
O:
1.0%
H:
0.23%
C:
-0.01%
MDT
|
$79.19
0.14%
0.0%
6.1M
|
Health Technology
|
-34.49%
|
O:
0.82%
H:
0.87%
C:
0.4%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-3.12%
|
O:
0.44%
H:
1.44%
C:
1.35%
BAX
|
$39.65
0.33%
0.0%
2.3M
|
Health Technology
|
-49.22%
|
O:
0.33%
H:
1.64%
C:
1.58%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
52.59%
|
O:
0.3%
H:
0.29%
C:
-0.28%
IART
|
News
|
$31.63
-0.97%
-0.98%
510K
|
Health Technology
|
-52.79%
|
O:
0.62%
H:
1.84%
C:
0.9%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
31.41%
|
O:
0.67%
H:
1.18%
C:
1.12%
stem cell
therapy
New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies
Published:
2021-10-05
(Crawled : 15:00)
- biospace.com/
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-3.82%
|
O:
0.36%
H:
1.91%
C:
0.15%
gene therapies
expansion
therapy
gene therapy
← Previous
1
2
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.